Key Takeaways
- NuScale holds the distinction of being the sole U.S. nuclear firm with NRC-approved SMR technology, positioning it ahead of competitors in regulatory approval.
- First quarter 2026 sales totaled a mere $565,000 — a staggering 95.8% decline from the prior year — falling drastically short of the $7 million analyst forecast.
- Shares currently hover between $12 and $13, representing a 65% decline from year-ago levels, far below the 52-week peak of $57.42.
- Director Corp Fluor dumped 13.5 million shares in April worth more than $159 million, part of a broader insider selling trend.
- Analyst consensus stands at “Hold” with a mean price target of $15.92, while institutional investors control 78.37% of shares outstanding.
NuScale Power (SMR) shares are languishing below the $13 mark, trading approximately 65% beneath their level from twelve months ago. This substantial discount between current valuation and future promise is capturing investor interest — though the underlying fundamentals present a mixed picture.
NuScale Power Corporation, SMR
The equity began Thursday’s session at $12.05, with a twelve-month trading band spanning $8.85 on the low end to $57.42 at its peak. The company commands a market capitalization in the $4.4–$4.5 billion range, an impressive valuation for an enterprise that generated only $565,000 in quarterly revenue.
That first quarter performance wasn’t simply disappointing — it dramatically underperformed Wall Street’s $7 million projection. Sales plummeted 95.8% compared to the same period last year, while the firm recorded a $57 million operating deficit for the three-month period.
NuScale delivered earnings per share of -$0.14 in Q1, falling short of the -$0.11 consensus forecast. Full-year projections call for EPS of -$0.79.
Why NuScale Could Still Win
The optimistic thesis centers on regulatory advantage. NuScale stands alone among American nuclear reactor developers with an NRC-certified small modular reactor design. Competitors such as Oklo and Nano Nuclear Energy haven’t achieved this milestone and face potentially lengthy approval timelines.
NuScale is advancing two significant initiatives. The company is collaborating with a Romanian energy provider to construct a 462-megawatt facility at a decommissioned coal location. Stateside, through its partnership with ENTRA1, it’s pursuing 6 gigawatts of SMR deployment for the Tennessee Valley Authority.
Both developments remain years from completion, with no expected operational dates before 2030. For the present, NuScale operates as a pre-commercial enterprise carrying a multi-billion dollar market valuation.
The firm does maintain substantial liquidity — approximately $1 billion in total resources, encompassing $341 million in cash and cash equivalents. While this provides operational runway, it hasn’t yet translated into shareholder returns.
Heavy Insider Liquidation, Institutional Patience
Recent insider transactions warrant scrutiny. Over the past ninety days, company insiders liquidated more than 40 million shares valued at nearly $475 million. The most significant transaction involved Director Corp Fluor, which disposed of 13.5 million shares during April at an average sale price of $11.81, generating proceeds exceeding $159 million.
Company insiders currently retain just 1.28% ownership.
Conversely, institutional investors maintain a 78.37% stake in the company. Seven Grand Managers LLC established a fresh position valued at $1.77 million during the fourth quarter. Multiple additional funds — including MAI Capital Management and Harbour Investments — expanded their existing holdings.
Wall Street sentiment remains divided. B. Riley reduced its price target from $24 to $19 while maintaining a “Buy” recommendation. HSBC initiated coverage with a “Hold” rating and $13 target. Royal Bank of Canada lowered its objective from $21 to $14. TD Cowen downgraded the stock from “Buy” to “Hold” in February.
The aggregate view from 17 covering analysts is “Hold,” with a mean price objective of $15.92 — roughly 25% higher than current trading levels.
NuScale’s 50-day simple moving average stands at $11.41, while its 200-day moving average registers at $15.38, placing the stock in the middle of these technical indicators.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
